Catalog No.:AA006VQZ

50772-53-7 | 2-Chloro-n-(4-methyl-1,3-thiazol-2-yl)acetamide

Name: Name:2-Chloro-n-(4-methyl-1,3-thiazol-2-yl)acetamide
Brand: AABLOCKS
SKU: AA006VQZ
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

1mg

>95%

1 week

$299.00 $209.00

- +

5mg

>95%

1 week

$319.00 $223.00

- +

500mg

>95%

1 week

$339.00 $238.00

- +

>95%

1 week

$414.00 $290.00

- +

>95%

1 week

$813.00 $569.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA006VQZ

Chemical Name:

2-Chloro-n-(4-methyl-1,3-thiazol-2-yl)acetamide

CAS Number:

50772-53-7

Molecular Formula:

C6H7ClN2OS

Molecular Weight:

190.6506

MDL Number:

MFCD01233541

SMILES:

Cc1csc(n1)NC(=O)CCl

Properties

Storage:

Keep in dry area;-20 ℃;

Computed Properties

Complexity:

156

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

1.5

Downstream Synthesis Route

1603-91-4

79-04-9

50772-53-7

[1]CurrentPatentAssignee:TIANJININSTITUTEOFPHARMACEUTICALRESEARCH-US2011/281922,2011,A1Locationinpatent:Page/Pagecolumn3

[2]CurrentPatentAssignee:TIANJININSTITUTEOFPHARMACEUTICALRESEARCH-EP2404909,2012,A1Locationinpatent:Page/Pagecolumn5

[3]Reddy,TummalaR.K.;Li,Chan;Guo,Xiaoxia;Fischer,PeterM.;Dekker,LodewijkV.[BioorganicandMedicinalChemistry,2014,vol.22,#19,p.5378-5391]

[4]Bhargava,P.N.;Singh,P.R.[JournaloftheIndianChemicalSociety,1960,vol.37,p.241-243]

[5]Geronikaki;Hadjipavlou-Litina;Chatziopoulos;Soloupis[Molecules,2003,vol.8,#6,p.472-479]

[6]Turan-Zitouni,Guelhan;Demirayak,Seref;Oezdemir,Ahmet;Kaplancikli,ZaferAsim;Yildiz,MehmetTaha[EuropeanJournalofMedicinalChemistry,2004,vol.39,#3,p.267-272]

[7]Khanna,Smriti;Madan,Manjula;Vangoori,Akhila;Banerjee,Rahul;Thaimattam,Ram;JafarSadikBasha;Ramesh,Mullangi;Casturi,SeshagiriRao;Pal,Manojit[BioorganicandMedicinalChemistry,2006,vol.14,#14,p.4820-4833]

[8]Papadopoulou,Christina;Geronikaki,Athina;Hadjipavlou-Litina,Dimitra[IlFarmaco,2005,vol.60,#11-12,p.969-973]

[9]Demirayak,Seref;Ali,FatenDali;Osman,BalandSirvan;Tunali,Yagmur[Phosphorus,SulfurandSiliconandtheRelatedElements,2007,vol.182,#8,p.1793-1803]

[10]Locationinpatent:schemeortableZheng,Weihong;Degterev,Alexei;Hsu,Emily;Yuan,Junying;Yuan,Chengye[BioorganicandMedicinalChemistryLetters,2008,vol.18,#18,p.4932-4935]

[11]Locationinpatent:experimentalpartDelpire,Eric;Baranczak,Aleksandra;Waterson,AlexG.;Kim,Kwangho;Kett,Nathan;Morrison,RyanD.;ScottDaniels;DavidWeaver;Lindsley,CraigW.[BioorganicandMedicinalChemistryLetters,2012,vol.22,#14,p.4532-4535]

[12]Apostolidis;Liaras;Geronikaki;Hadjipavlou-Litina;Gavalas;Sokovic;Glamoclija;Ciric[BioorganicandMedicinalChemistry,2013,vol.21,#2,p.532-539]

[13]Duran,Murat;Demirayak,Seref[MedicinalChemistryResearch,2013,vol.22,#9,p.4110-4124]

[14]Zablotskaya,Alla;Segal,Izolda;Geronikaki,Athina;Eremkina,Tatiana;Belyakov,Sergey;Petrova,Marina;Shestakova,Irina;Zvejniece,Liga;Nikolajeva,Vizma[EuropeanJournalofMedicinalChemistry,2013,vol.70,p.846-856]

[15]Gundogdu-Karaburun,Nalan[Lettersindrugdesignanddiscovery,2014,vol.11,#6,p.814-823]

[16]Yurttaş,Leyla;Özkay,Yusuf;Duran,Murat;Turan-Zitouni,Gülhan;Özdemir,Ahmet;Cantürk,Zerrin;Küçükoğlu,Kaan;Kaplancıklı,ZaferAsım[Phosphorus,SulfurandSiliconandtheRelatedElements,2016,vol.191,#8,p.1166-1173]

[17]Pawar,ChandrakantD.;Sarkate,AniketP.;Karnik,KshipraS.;Bahekar,SushilkumarS.;Pansare,DattatrayaN.;Shelke,RohiniN.;Jawale,ChetanS.;Shinde,DevanandB.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#15,p.3525-3528]

[18]Aguilera,RenatoJ.;Choe,Jun-yong;Hess,JessicaD.;Iancu,CristinaV.;Macias,LucasantiagoHenze;Meyer-Almes,Franz-Josef;Mrowka,Piotr;Ramaa,C.S.;Tilekar,Kalpana;Upadhyay,Neha[EuropeanJournalofMedicinalChemistry,2020,vol.202]

[19]Berk,Barkın;Biltekin,SevdeNur;Demirayak,Şeref;Ertaş,Merve;Yurttaş,Leyla[Phosphorus,SulfurandSiliconandtheRelatedElements,2022]

50772-53-7

22876-19-3

2-(5-chloro-benzooxazol-2-ylsulfanyl)-N-(4-methyl-thiazol-2-yl)-acetamide

[1]EuropeanJournalofMedicinalChemistry,2004,vol.39,p.267-272

50772-53-7

25369-78-2

2-(5-chloro-1H-benzoimidazol-2-ylsulfanyl)-N-(4-methyl-thiazol-2-yl)-acetamide

[1]Turan-Zitouni,Guelhan;Demirayak,Seref;Oezdemir,Ahmet;Kaplancikli,ZaferAsim;Yildiz,MehmetTaha[EuropeanJournalofMedicinalChemistry,2004,vol.39,#3,p.267-272]

58255-18-8

50772-53-7

4-methyl-2-{{2-methyl(thiophene-2-methyl)aminoacetyl}amino}thiazolehydrochloride

[1]Patent:CN103664930,2016,B

58255-18-8

50772-53-7

4-methyl-2-{{2-methyl(thiophene-2-methyl)aminoacetyl}amino}thiazole

[1]Patent:CN103664930,2016,B.Locationinpatent:Paragraph0035-0037;0041

Literature

Title: 2-[(2,6-Dichloro-benz-yl)amino]-N-(4-methyl-thia-zol-2-yl)acetamide.

Journal: Acta crystallographica. Section E, Structure reports online 20100301

Title: Synthesis of some 2-[(benzazole-2-yl)thioacetylamino]thiazole derivatives and their antimicrobial activity and toxicity.